Efficacy of Ixekizumab in Patients Previously Treated with IL-17 Inhibitors Main Article Content Kim A Papp Andrew Blauvelt John Sullivan Et al. Keywords Abstract Abstract not available. Disclosures: Study sponsored by Eli Lilly & Company. Copyright 2018 SKIN Article Sidebar Poster PDF Published Dec 17, 2018 DOI https://doi.org/10.25251/skin.2.supp.107 Article Details How to Cite Papp, K. A., Blauvelt, A., Sullivan, J., & al., E. (2018). Efficacy of Ixekizumab in Patients Previously Treated with IL-17 Inhibitors. SKIN The Journal of Cutaneous Medicine, 2, S118. https://doi.org/10.25251/skin.2.supp.107 More Citation Formats ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Issue Vol. 2 (2018): Supplemental Issue: Scientific Posters & Abstracts Presented at 2018 Fall Clinical Dermatology Conference®-Las Vegas Section Psoriasis This work is licensed under a Creative Commons Attribution 4.0 International License. Authors transfer copyright to the publisher as part of the journal publishing agreement.All reprints are subject to the reprint policy.